Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Amber Yates, MD
Healthcare Provider Associate Director
Pediatric Hematology-Oncology Fellowship Program
Texas Children's Hospital
6701 Fannin Street
Suite 1580
Houston, Texas, United States
Dr. Amber Yates is an Associate Director of the Pediatric Hematology-Oncology Fellowship Program. She is also Co-Director of the Sickle Cell Program, a member of the Hematology Center and Associate Professor Of Pediatrics at Baylor College of Medicine.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
Representative Publications:
Hydroxyurea treatment of children with hemoglobin SC disease
Related Content
-
Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: The role ...Despite its rarity in the United States,...
-
2023 NHLBI Annual Sickle Cell Disease Research MeetingSave the Date for the NHLBI Annual Sickl...
-
Lori E. Crosby, PsyDDr. Crosby works in Cincinnati, Ohio and...
-
Pierrette (P) Mimi Poinsett, MDDr. Pierrette Mimi Poinsett is a physici...
-
Boston Children’s Hospital receives grant for sickle cell disease researchThe Bill and Melinda Gates Foundation aw...
-
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
-
The Sickle Cell Infusion Center at Johns HopkinsThe Sickle Cell Center for Adults is ded...
+myBinder